<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03486548</url>
  </required_header>
  <id_info>
    <org_study_id>768/2560(EC1)</org_study_id>
    <nct_id>NCT03486548</nct_id>
  </id_info>
  <brief_title>Analgesic Efficacy of Adding SCB With Low Concentration Bupivacaine Combined With Dexamethasone on Pain After TKA</brief_title>
  <official_title>Analgesic Efficacy of Adding SCB With Low Concentration Bupivacaine Combined With Dexamethasone to ACB and Periarticular Injection on Postoperative Pain After TKA: Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluate the efficacy of adding popliteal sciatic nerve block with low
      concentration bupivacaine and dexamethasone to abductor canal block for total knee
      arthroplasty in patient with NSAIDs prescribing precaution. Half of participants will receive
      popliteal sciatic nerve block, abductor canal block and periarticular injection, while the
      other half will receive a sham block, abductor canal block and periarticular injection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After informed and consent, all patients will be devided into two groups, Sciatic group
      (group S) and Controlled group (group C). All patients will receive adductor canal block,
      then patients in group S will receive Sciatic nerve block with low concentration bupivacaine
      and dexamethasone while partients in group C will receive sham block. All patient will
      receive spinal anesthesia and intraoperative periarticular injection.

      Postoperative pain score, muscle strength, total morphine consumption and adverse events will
      be record in case record form.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2018</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain score at rest</measure>
    <time_frame>postoperative 24 hours</time_frame>
    <description>postoperative pain score at rest at 24 hour</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative pain score at anterior and posterior site of knee</measure>
    <time_frame>postoperative 24 hours</time_frame>
    <description>postoperative pain score at anterior and posterior site of knee at 24 hour</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative pain score on 45 degree knee flexion and physical therapy</measure>
    <time_frame>postoperative 24 hours</time_frame>
    <description>postoperative pain score on 45 degree knee flexion and physical therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of tibialis anterior muscle weakness</measure>
    <time_frame>postoperative 24 hours</time_frame>
    <description>level of tibialis anterior muscle weakness in 24 hour</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse events</measure>
    <time_frame>postoperative 24 hours</time_frame>
    <description>perioperative adverse events such as LAST, hypotension, nausea and vomitting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total morphine consumption in postoperative 24 hours</measure>
    <time_frame>postoperative 24 hours</time_frame>
    <description>total morphine consumption in postoperative 24 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction</measure>
    <time_frame>postoperative 24 hours</time_frame>
    <description>patient satisfaction score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of hospital stay</measure>
    <time_frame>7 days</time_frame>
    <description>length of hospital stay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Total Knee Arthroplasty</condition>
  <condition>Adductor Canal Block</condition>
  <condition>Sciatic Nerve Block</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>adductor canal block with sham block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sciatic group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>adductor canal block with popliteal sciatic nerve block</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacaine and dexamethasone</intervention_name>
    <description>adductor canal block with 0.33% bupivacaine 15 ml with ultrasound guided popliteal sciatic block with 0.125% bupivacaine 20 ml and dexamethasone 5 mg</description>
    <arm_group_label>sciatic group</arm_group_label>
    <other_name>bupivacaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacaine and lidocaine</intervention_name>
    <description>adductor canal block with 0.33% bupivacaine 15 ml with ultrasound at popliteal sciatic area and subcutaneous infiltration popliteal area with 2% lidocaine 1 ml</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>ultrasound</description>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>sciatic group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient scheduled for single total knee arthroplasty

          -  patient with NSAIDs prescribing precautions such as history of NSAIDs allergy, Chronic
             kidney disease (GFR&lt; 50 ml/min), history of ischemic heart disease or cerebrovascular
             disease

        Exclusion Criteria:

          -  patient refusal

          -  body weight less than 45 kg

          -  history of allergy to bupivacaine or dexamethasone

          -  uncontrolled diabetes mellitus

          -  contraindicated for spinal block, adductor canal block or sciatic nerve block

          -  inability to assess pain score (cognitive or psychiatric history)

          -  patient scheduled for revision TKA

          -  preexisting neuropathy or neurological deficit in lower extremity

          -  preexisting chronic pain (prolonged use of oral morphine 20 mg/day or equivalent)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Busara Sirivanasandha, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesia, Siriraj hospital, Mahidol university</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Busara Sirivanasandha, MD</last_name>
    <phone>+6624197995</phone>
    <email>busarasiri@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Siriraj Hospital, Mahidol University</name>
      <address>
        <city>Bangkoknoi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Busara Sirirvanadandha, MD</last_name>
      <phone>+66851429656</phone>
      <email>busarasiri@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2018</study_first_submitted>
  <study_first_submitted_qc>April 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 3, 2018</study_first_posted>
  <last_update_submitted>April 2, 2018</last_update_submitted>
  <last_update_submitted_qc>April 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>popliteal sciatic nerve block</keyword>
  <keyword>total knee artgroplasty</keyword>
  <keyword>adductor canal block</keyword>
  <keyword>dexamethasone</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

